Guggenheim Capital’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.64M | Buy |
12,245
+3,097
| +34% | +$1M | 0.03% | 521 |
|
|
2025
Q4 | $2.78M | Buy |
9,148
+2,118
| +30% | +$693K | 0.02% | 580 |
|
|
2025
Q3 | $2.4M | Sell |
7,030
-1,007
| -13% | -$306K | 0.02% | 639 |
|
|
2025
Q2 | $1.95M | Sell |
8,037
-644
| -7% | -$158K | 0.02% | 663 |
|
|
2025
Q1 | $2.36M | Buy |
8,681
+4,112
| +90% | +$961K | 0.02% | 598 |
|
|
2024
Q4 | $844K | Buy |
+4,569
| New | +$934K | 0.01% | 994 |
|
|
2022
Q1 | – | Sell |
-777
| Closed | -$211K | – | 2193 |
|
|
2021
Q4 | $211K | Sell |
777
-6,499
| -89% | -$2.19M | ﹤0.01% | 2019 |
|
|
2021
Q3 | $2.64M | Sell |
7,276
-1,327
| -15% | -$434K | 0.02% | 912 |
|
|
2021
Q2 | $2.95M | Buy |
8,603
+677
| +9% | +$224K | 0.02% | 895 |
|
|
2021
Q1 | $2.76M | Sell |
7,926
-3,064
| -28% | -$1.01M | 0.02% | 867 |
|
|
2020
Q4 | $2.84M | Buy |
10,990
+4,408
| +67% | +$1.21M | 0.02% | 813 |
|
|
2020
Q3 | $1.89M | Sell |
6,582
-9,862
| -60% | -$2.32M | 0.01% | 919 |
|
|
2020
Q2 | $3.1M | Buy |
16,444
+2,453
| +18% | +$399K | 0.02% | 706 |
|
|
2020
Q1 | $1.72M | Sell |
13,991
-2,935
| -17% | -$459K | 0.02% | 851 |
|
|
2019
Q4 | $2.81M | Buy |
+16,926
| New | +$2.81M | 0.02% | 906 |
|
|
2018
Q2 | – | Sell |
-5,583
| Closed | -$938K | – | 2639 |
|
|
2018
Q1 | $938K | Buy |
5,583
+558
| +11% | +$75.6K | ﹤0.01% | 2103 |
|
|
2017
Q4 | $491K | Sell |
5,025
-13,675
| -73% | -$1.25M | ﹤0.01% | 2366 |
|
|
2017
Q3 | $1.94M | Sell |
18,700
-2,151
| -10% | -$160K | 0.01% | 1692 |
|
|
2017
Q2 | $938K | Buy |
20,851
+801
| +4% | +$31.6K | ﹤0.01% | 2113 |
|
|
2017
Q1 | $735K | Sell |
20,050
-1,999
| -9% | -$72.8K | ﹤0.01% | 2257 |
|
|
2016
Q4 | $670K | Buy |
+22,049
| New | +$693K | ﹤0.01% | 2316 |
|
Other funds holding ONC
BBA
HA
